Novartis AG ADR buy The Goldman Sachs Group, Inc.
Start price
30.05.24
/
50%
€92.80
Target price
30.05.25
€110.78
Performance (%)
9.91%
End price
31.05.25
€102.00
Summary
This prediction ended on 31.05.25 with a price of €102.00. The BUY prediction by The_Goldman_Sachs_Gr finished with a performance of 9.91%. The_Goldman_Sachs_Gr has a follow-up prediction for Novartis AG ADR, but this time predicts that Novartis AG ADR is a Sell. Dividends of €3.87 are taken into consideration when calculating the performance. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | -1.413% | -1.413% | 30.374% |
| iShares Core DAX® | -0.975% | -4.716% | 4.787% |
| iShares Nasdaq 100 | 1.163% | 1.881% | 20.234% |
| iShares Nikkei 225® | -1.593% | -5.385% | 31.353% |
| iShares S&P 500 | -0.278% | 0.327% | 13.911% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Novartis AG ADR
Novartis AG ADR
Start price
Target price
Perf. (%)
€106.50
12.09.25
12.09.25
€100.61
12.09.26
12.09.26
30.99%
10.03.26
10.03.26
